Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ABDUL RAFEH NAQASH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1528499712
CMS profile
4217943
Location
OKLAHOMA CITY, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$11,838.80

9 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $10,281.98 4
Consulting Fee $1,098.58 1
Food and Beverage $458.24 4

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
JAZZ PHARMACEUTICALS INC. $11,539.55 6
PFIZER INC. $135.00 1
AstraZeneca Pharmaceuticals LP $128.78 1
GENZYME CORPORATION $35.47 1

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ABDUL RAFEH NAQASH

NPI 1528499712 · CMS profile ID 4217943

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

OKLAHOMA CITY, OK

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1528499712?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ABDUL RAFEH NAQASH, NPI 1528499712, CMS profile ID 4217943. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1528499712?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ABDUL RAFEH NAQASH, NPI 1528499712, CMS profile ID 4217943. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1528499712?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ABDUL RAFEH NAQASH, NPI 1528499712, CMS profile ID 4217943, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–9 of 9 matching records. This page contains 9 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1528499712?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

9 matching records · $11,838.80 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 9 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–9 of 9.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GENZYME CORPORATION $35.4710/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139887196 CMS
AstraZeneca Pharmaceuticals LP $128.7809/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105868313 CMS
PFIZER INC. $135.0006/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131331821 CMS
JAZZ PHARMACEUTICALS INC. $1,531.0404/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219363 CMS
JAZZ PHARMACEUTICALS INC. $1,098.5804/19/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219361 CMS
JAZZ PHARMACEUTICALS INC. $8,534.9504/18/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219359 CMS
JAZZ PHARMACEUTICALS INC. $40.0004/17/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219357 CMS
JAZZ PHARMACEUTICALS INC. $175.9904/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219355 CMS
JAZZ PHARMACEUTICALS INC. $158.9904/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150219353 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $222.96 15
PY2020 $13.46 1
PY2023 $7,378.87 2
PY2024 $11,838.80 9
PY2025 $3,667.10 15

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $443.22 1
PY2025 Principal investigator $340,851.02 231
PY2024 Principal investigator $416,792.13 124
PY2023 Principal investigator $259,878.25 67
PY2022 Principal investigator $92,521.38 35

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

232 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $600.00 12/31/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE
A Phase 1 First-in-Human Study Evaluating Safety, Pharmacokinetics and Efficacy of ABBV-706 as Monotherapy and in Combination with Budigalimab (ABBV-181), Carboplatin, or Cisplatin in Adult Subjects with Advanced Solid Tumors No dispute reported 06/30/2026 1202534531
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $270.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208961
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $455.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208963
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $450.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208965
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,000.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208967
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $75.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209031
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $88.75 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209033
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $75.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209035
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $375.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209037
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $500.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209039
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $93.75 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209041
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $96.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209043
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209045
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $156.25 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209047
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $94.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209049
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $120.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209051
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209053
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $156.25 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209055
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $135.00 12/05/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209057
Principal investigator 1 PFIZER INC. $1,500.00 11/24/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228714963
Principal investigator 1 PFIZER INC. $1,500.00 11/24/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228715047
Principal investigator 1 PFIZER INC. $2,850.00 11/24/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF TUCATINIB OR PLACEBO IN COMBINATION WITH ADOTRASTUZUMAB EMTANSINE TDM1 FOR SUBJECTS WITH UNRESECTABLE LOCALLYADVANCED OR METASTATIC HER2 BREAST CANCER HER2CLIMB02 No dispute reported 06/30/2026 1228728397
Principal investigator 1 PFIZER INC. $1,500.00 11/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228714965
Principal investigator 1 PFIZER INC. $1,589.00 11/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228715045
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 11/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252815
Principal investigator 1 Coherus Oncology, Inc. $65.25 11/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252820
Principal investigator 1 Coherus Oncology, Inc. $375.00 11/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252823
Principal investigator 1 Coherus Oncology, Inc. $1,228.00 11/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252827
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $227.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207854
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207856
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $208.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207858
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207860
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $367.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207874
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207876
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207878
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $348.75 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250207880
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $208.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208977
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208979
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $227.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208981
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208993
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208995
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $227.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208997
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $227.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208999
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209001
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $223.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209003
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209005
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209007
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $223.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209079
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209081
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $223.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209085
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $37.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209087
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $220.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209089
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $367.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209091
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209093
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $255.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209095
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209097
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $208.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209099
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $220.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209101
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $345.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209103
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209105
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209107
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209109
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $367.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209111
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209113
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $37.50 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209115
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $326.88 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209117
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $53.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209119
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $208.13 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209121
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $220.63 10/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209123
Principal investigator 1 PFIZER INC. $900.00 10/27/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228714961
Principal investigator 1 Coherus Oncology, Inc. $3,480.75 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252774
Principal investigator 1 Coherus Oncology, Inc. $2,855.25 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252779
Principal investigator 1 Coherus Oncology, Inc. $1,456.88 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252783
Principal investigator 1 Coherus Oncology, Inc. $125.00 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252786
Principal investigator 1 Coherus Oncology, Inc. $2,909.25 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252789
Principal investigator 1 Coherus Oncology, Inc. $1,344.38 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252793
Principal investigator 1 Coherus Oncology, Inc. $1,203.75 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252796
Principal investigator 1 Coherus Oncology, Inc. $506.25 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252801
Principal investigator 1 Coherus Oncology, Inc. $2,660.63 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252805
Principal investigator 1 Coherus Oncology, Inc. $1,372.50 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252808
Principal investigator 1 Coherus Oncology, Inc. $2,126.25 10/24/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252811
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252746
Principal investigator 1 Coherus Oncology, Inc. $2,660.63 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252752
Principal investigator 1 Coherus Oncology, Inc. $1,456.88 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252757
Principal investigator 1 Coherus Oncology, Inc. $3,480.75 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252761
Principal investigator 1 Coherus Oncology, Inc. $1,344.38 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252765
Principal investigator 1 Coherus Oncology, Inc. $2,909.25 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252769
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 10/17/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252908
Principal investigator 1 Coherus Oncology, Inc. $156.25 10/10/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252742
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208983
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $375.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208985
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $135.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208987
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $375.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208989
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $135.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208991
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $93.75 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209009
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $156.25 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209011
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $156.25 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209013
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209015
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $96.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209017
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $93.75 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209019
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,090.00 10/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209021
Principal investigator 1 PFIZER INC. $1,500.00 09/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228723326
Principal investigator 1 PFIZER INC. $4,500.00 09/29/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228757422
Principal investigator 1 PFIZER INC. $1,500.00 09/22/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228757143
Principal investigator 1 PFIZER INC. $1,500.00 09/15/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228760307
Principal investigator 1 Immunocore Limited $550.00 09/12/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146241
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 08/27/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252880
Principal investigator 1 PFIZER INC. $1,500.00 08/25/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228767367
Principal investigator 1 Coherus Oncology, Inc. $430.00 08/15/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252865
Principal investigator 1 Coherus Oncology, Inc. $40.00 08/15/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252868
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 08/15/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252871
Principal investigator 1 Coherus Oncology, Inc. $119.00 08/15/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252875
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 08/15/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252884
Principal investigator 1 PFIZER INC. $1,500.00 07/21/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228772414
Principal investigator 1 PFIZER INC. $3,925.00 07/21/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228786337
Principal investigator 1 Merck Sharp & Dohme LLC $4,487.40 07/09/2025 Non-covered Recipient Entity
Stephenson Cancer Center
Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High Risk Stage II Melanoma# A Randomized, Double-blind Phase III Study KEYNOTE 716 No dispute reported 06/30/2026 1232927033
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $624.00 06/13/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208957
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 06/13/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208959
Principal investigator 1 Immunocore Limited $550.00 06/09/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146237
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 05/28/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252844
Principal investigator 1 Coherus Oncology, Inc. $375.00 05/28/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252848
Principal investigator 1 Coherus Oncology, Inc. $275.00 05/28/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252851
Principal investigator 1 Coherus Oncology, Inc. $1,228.00 05/28/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252856
Principal investigator 1 Coherus Oncology, Inc. $195.00 05/28/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252861
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $949.00 05/23/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208947
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 05/23/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208949
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $159.00 05/23/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208951
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $747.00 05/23/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208953
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 05/09/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250208955
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 04/25/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252840
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 04/25/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252888
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 04/25/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252893
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 04/25/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252897
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $556.33 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209595
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209597
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209599
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $556.33 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209601
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209603
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209605
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $397.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209607
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $347.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209609
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209611
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $418.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209613
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,690.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209615
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $356.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209617
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209619
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $347.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209621
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $422.57 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209623
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209625
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $360.08 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209627
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209629
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $431.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209631
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $360.08 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209633
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209635
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209637
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209639
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209641
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209643
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $368.20 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209645
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209647
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209649
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209651
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $356.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209653
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209655
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $347.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209657
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $347.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209659
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $310.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209661
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209663
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209665
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $311.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209667
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $493.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209669
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209671
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $556.33 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209673
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209675
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $310.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209677
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209679
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $556.33 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209681
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $443.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209683
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $556.33 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209685
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $316.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209687
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $431.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209689
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209691
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $341.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209693
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209695
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $94.38 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209697
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $285.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209699
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $418.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209701
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209703
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $463.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209705
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209707
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209709
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $372.58 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209711
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $493.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209713
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209715
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $310.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209717
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $446.87 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209719
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209721
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209723
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209725
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $422.57 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209727
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $431.25 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209729
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209731
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $94.38 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209733
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $468.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209735
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $56.88 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209737
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $418.75 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209739
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209741
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $360.08 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209743
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $347.50 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209745
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $75.62 04/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209747
Principal investigator 1 Immunocore Limited $255.15 04/16/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146239
Recipient Regeneron Pharmaceuticals, Inc. $443.22 04/05/2025 Covered Recipient Physician A MULTICENTER, OPEN-LABEL, PHASE 2 STUDY OF INTRATUMORAL CMP-001 IN COMBINATION WITH INTRAVENOUS NIVOLUMAB IN SUBJECTS WITH REFRACTORY UNRESECTABLE OR METASTATIC MELANOMA No dispute reported 06/30/2026 1184120863
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $375.00 03/28/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209061
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 03/28/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209063
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $588.00 03/28/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209065
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $588.00 03/28/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209067
Principal investigator 1 Coherus Oncology, Inc. $1,850.00 03/21/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252836
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 02/14/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209059
Principal investigator 1 Coherus Oncology, Inc. $2,909.25 02/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252833
Principal investigator 1 Coherus Oncology, Inc. $2,909.25 02/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252901
Principal investigator 1 Coherus Oncology, Inc. $2,909.25 02/07/2025 Non-covered Recipient Entity
Sarah Cannon Research Institute, LLC
SRF388-101 No dispute reported 06/30/2026 1235252904
Principal investigator 1 Genentech, Inc. $21,000.00 02/03/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
Ph1 Solid Tumor Dose Escalation and Exploratory Cohorts No dispute reported 06/30/2026 1211650624
Principal investigator 1 Immunocore Limited $178.60 01/24/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146233
Principal investigator 1 Immunocore Limited $255.15 01/24/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146235
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 01/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209075
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $337.50 01/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209077
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $2,500.00 01/17/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE, LLC
Not supplied No dispute reported 06/30/2026 1250209083
Principal investigator 1 Eli Lilly and Company $115,937.20 01/15/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH INSTITUTE LLC
AN OPEN-LABEL, MULTICENTER STUDY OF LOXO-435 (LY3866288) IN ADVANCED SOLID TUMOR MALIGNANCIES WITH FGFR3 ALTERATIONS No dispute reported 06/30/2026 1187888176
Principal investigator 1 Immunocore Limited $2,500.00 01/15/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146227
Principal investigator 1 Immunocore Limited $18,500.00 01/15/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146229
Principal investigator 1 Immunocore Limited $3,300.00 01/15/2025 Non-covered Recipient Entity
Board of Regents of the University of Oklahoma Health Sciences Center
Randomized Phase 2/3 Study of Tebentafusp Monotherapy or with Pembrolizumab Versus Chemotherapy in HLA-A*02:01-positive Patients with Previously Treated Metastatic Cutaneous Melanoma (TEBE-CM) No dispute reported 06/30/2026 1212146231
Principal investigator 1 PFIZER INC. $1,500.00 01/06/2025 Non-covered Recipient Entity
SARAH CANNON RESEARCH
A PHASE 1 STUDY OF SGNB6A IN ADVANCED SOLID TUMORS No dispute reported 06/30/2026 1228801907